Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens–Johnson syndrome and toxic epidermal necrolysis

Publisher： John Wiley & Sons Inc

E-ISSN： 1346-8138|42|8|768-777

ISSN： 0385-2407

Source： THE JOURNAL OF DERMATOLOGY, Vol.42, Iss.8, 2015-08, pp. : 768-777

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Research Directions in Genetic Predispositions to Stevens–Johnson Syndrome / Toxic Epidermal Necrolysis

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 103, Iss. 3, 2018-03 ,pp. : 390-394

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intravenous Ulinastatin Therapy for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Pediatric Patients

By  

International Archives of Allergy and Immunology, Vol. 127, Iss. 1, 2002-02 ,pp. : 89-94

Karger

Access to resources Recommend Favorite

Severe Stevens‐Johnson syndrome/toxic epidermal necrolysis overlap syndrome—beyond skin involvement

By  

PEDIATRIC DERMATOLOGY, Vol. 35, Iss. 1, 2018-01 ,pp. : e17-e19

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stevens‐Johnson Syndrome and Toxic Epidermal Necrolysis Are Severity Variants of the Same Disease which Differs from Erythema Multiforme

By  

THE JOURNAL OF DERMATOLOGY, Vol. 24, Iss. 11, 1997-11 ,pp. : 726-729

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hydrogen-Cyanamide-Related Severe Cutaneous Reactions Simulating Erythema multiforme and Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

By  

Exogenous Dermatology, Vol. 3, Iss. 1, 2005-06 ,pp. : 26-29

Karger

Access to resources Recommend Favorite